Clearpoint Neuro (CLPT) financial statements
Clearpoint Neuro reported revenue of $37M in fiscal 2025, up 23.0% a year over 9 years.
Net income was -$26M and the operating margin -65.4%, against -130.3% in 2016.
Free cash flow was -$24M.
The diluted share count rose 928% over the period (dilution).
Revenue and free cash flow
Fiscal years, $ billions.
Income statement
Fiscal years, from Clearpoint Neuro's 10-K filings with the SEC.
| Fiscal year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $6M | $7M | $7M | $11M | $13M | $16M | $21M | $24M | $31M | $37M |
| Cost of revenue | $3M | $3M | $2M | $4M | $4M | $5M | $7M | $10M | $12M | $14M |
| Gross profit | $3M | $4M | $5M | $7M | $9M | $11M | $14M | $14M | $19M | $23M |
| Research and development | $3M | $3M | $2M | $3M | $5M | $9M | $11M | $12M | $12M | $14M |
| Selling, general and admin | $4M | $4M | $4M | $4M | $5M | $8M | $10M | $12M | $12M | $16M |
| Operating income | -$7M | -$6M | -$5M | -$5M | -$6M | -$13M | -$16M | -$22M | -$20M | -$24M |
| Interest expense | $1M | $872,926 | $980,383 | $955,000 | $1M | $973,000 | $81,000 | — | $518,000 | $2M |
| Pre-tax income | — | — | — | — | — | — | — | — | -$19M | -$25M |
| Income tax | — | — | — | — | $0 | $0 | $0 | $8,000 | $12,000 | $55,000 |
| Net income | -$8M | -$7M | -$6M | -$6M | -$7M | -$14M | -$16M | -$22M | -$19M | -$26M |
| EPS (diluted) | -$2.93 | -$0.93 | -$0.56 | -$0.42 | -$0.43 | -$0.69 | -$0.68 | -$0.90 | -$0.70 | -$0.90 |
| Diluted shares | 3M | 8M | 11M | 13M | 16M | 21M | 24M | 25M | 27M | 28M |
| Gross margin | 54.0% | 60.7% | 66.9% | 64.9% | 71.1% | 68.2% | 65.8% | 56.8% | 60.9% | 61.4% |
| Operating margin | -130.3% | -85.9% | -71.4% | -41.0% | -48.5% | -82.1% | -79.5% | -93.7% | -62.9% | -65.4% |
| Net margin | -140.4% | -97.1% | -83.8% | -49.4% | -52.9% | -88.4% | -80.0% | -92.2% | -60.3% | -69.1% |
Balance sheet
Fiscal years, from Clearpoint Neuro's 10-K filings with the SEC.
| Fiscal year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and short-term investments | $3M | $9M | $3M | $6M | $20M | $54M | $37M | $23M | $20M | $46M |
| Receivables | $865,943 | $949,415 | $1M | $1M | $2M | $2M | $3M | $3M | $5M | $7M |
| Inventory | $2M | $2M | $2M | $3M | $3M | $5M | $9M | $8M | $7M | $8M |
| Total current assets | $6M | $13M | $7M | $10M | $25M | $62M | $51M | $36M | $33M | $64M |
| Property, plant and equipment | $328,249 | $267,667 | $377,706 | $447,000 | $319,000 | $539,000 | $806,000 | $1M | $2M | $3M |
| Goodwill | — | — | — | — | — | — | — | — | $7M | $7M |
| Total assets | $7M | $14M | $8M | $12M | $30M | $66M | $55M | $43M | $39M | $98M |
| Total current liabilities | $3M | $4M | $2M | $4M | $3M | $5M | $7M | $7M | $10M | $11M |
| Total liabilities | $8M | $8M | $6M | $7M | $27M | $17M | $19M | $21M | $14M | $70M |
| Shareholders' equity | -$756,069 | $6M | $2M | $5M | $2M | $49M | $37M | $21M | $25M | $28M |
| Net debt | -$3M | -$9M | -$3M | -$6M | -$20M | -$54M | -$28M | -$23M | -$20M | -$46M |
Cash flow
Fiscal years, from Clearpoint Neuro's 10-K filings with the SEC.
| Fiscal year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$6M | -$6M | -$5M | -$3M | -$8M | -$13M | -$16M | -$14M | -$9M | -$24M |
| Capital spending | $101,002 | $26,752 | $63,490 | $10,000 | $41,000 | $168,000 | $253,000 | $717,000 | $275,000 | $522,000 |
| Free cash flow | -$6M | -$6M | -$5M | -$3M | -$8M | -$13M | -$16M | -$14M | -$9M | -$24M |
| Stock-based compensation | $1M | $1M | $1M | $799,000 | $1M | $2M | $4M | $6M | $7M | $8M |
| Free cash flow margin | -103.0% | -81.6% | -63.8% | -25.5% | -61.2% | -78.9% | -79.9% | -60.3% | -29.4% | -66.1% |
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for CLPT.
Open CLPT in InvestinglyQuestions
What was Clearpoint Neuro's revenue in 2025?
$37M in fiscal 2025, from its 10-K filing.
How much free cash flow does Clearpoint Neuro generate?
-$24M in fiscal 2025 (operating cash flow minus capital spending).
From Clearpoint Neuro's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.